ReviewCardiovascular drugs and therapy2023

Cholesterol Lowering Biotechnological Strategies: From Monoclonal Antibodies to Antisense Therapies. A Pre-Clinical Perspective Review.

S Bellosta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.